Recent advances in understanding chemotherapy-induced peripheral neuropathy [version 1; peer review: 2 approved]
Chemotherapy-induced peripheral neuropathy (CIPN) is a common cause of pain and poor quality of life for those undergoing treatment for cancer and those surviving cancer. Many advances have been made in the pre-clinical science; despite this, these findings have not been translated into novel preven...
Main Authors: | Richard Gordon-Williams, Paul Farquhar-Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-03-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-177/v1 |
Similar Items
-
Recent advances in understanding frontotemporal degeneration [version 1; peer review: 2 approved]
by: Barbara Borroni, et al.
Published: (2019-12-01) -
Recent advances in understanding mesenchymal stromal cells [version 1; peer review: 3 approved]
by: Erika Rendra, et al.
Published: (2020-02-01) -
Recent advances in understanding and managing resistant/refractory hypertension [version 1; peer review: 2 approved]
by: Michael Doumas, et al.
Published: (2020-03-01) -
Recent advances in understanding Candida albicans hyphal growth [version 1; peer review: 4 approved]
by: Robert A. Arkowitz, et al.
Published: (2019-05-01) -
Recent advances in understanding and managing pediatric inflammatory bowel disease [version 1; peer review: 2 approved]
by: Bhaskar Gurram, et al.
Published: (2019-12-01)